Radiation-Induced Breast Cancer Attributable to Mammography Screening: Estimation for France in 2019
Journal of Breast Imaging · 2026
DOI: 10.1093/jbi/wbaf075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Breast Imaging, 2026. Verfasst von Nicolas Minier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'épidémiologie des rayonnements ionisants (LEPID), Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), Fontenay-aux-Roses, France. Hauptthemen laut MEDLINE: Neoplasms, Radiation-Induced, Breast Neoplasms, Mammography, Early Detection of Cancer. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
Despite their established clinical benefits, breast cancer screening examinations expose women to ionizing radiation (IR) and call for vigilance regarding protocols and practices. This study estimates the population attributable risk (PAR) of radiation-induced breast cancer in France in 2019 that is attributable to past exposure to IR through screening performed in women aged 40 to 74 years old.
Methods
Breast cancer screening practices were reconstituted for the period 1980 to 2019. Records of recent years were built based on French National Health Data System. An estimation was made for earlier years based on the available literature and expert knowledge. Women diagnosed with a history of breast cancer before mammography were excluded. Absorbed glandular doses to the breast were modeled based on existing literature and reports on French practices. Excess breast cancer cases were estimated using 2 radiation-risk models (Biologic Effects of Ionizing Radiation VII and the International Commission on Radiological Protection).
Results
Of roughly 55 000 new breast cancer cases diagnosed in 2019 in women at least 40 years old, we estimate that approximately 27 might be attributable to past exposures to IR associated with breast cancer screening between the ages of 50 and 74 years. This leads to a PAR of 0.048%. In addition, about 16 cases might be attributable to screening between ages 40 and 49 years, with a PAR of approximately 0.030%.
Conclusion
The contribution of breast cancer screening to the breast cancer burden in France is limited. Efforts to limit the dose delivered to the breast must continue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratoire d'épidémiologie des rayonnements ionisants (LEPID), Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), Fontenay-aux-Roses, France.
- ESDP, Université Paris-Saclay, Villejuif, France.
- Unité d'Expertise en Radioprotection Médicale (UEM), Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), Fontenay-aux-Roses, France.
- Direction appui traitement et analyse de données (DATA), Santé publique France, Saint-Maurice, France.
- Département de radiologie, Centre Oscar Lambret, Lille, France.
- Direction de la recherche et de l'expertise en santé, Autorité de Sûreté Nucléaire et de Radioprotection (ASNR), Fontenay-aux-Roses, France.
ORCID-Profile: Nicolas Minier, Christophe Bonaldi
Zitieren
APA
Minier, N., Sauce, J., Sage, J., Bonaldi, C., Ceugnart, L., Cléro, E., Laurier, D., Bernier, M. O., & Rogel, A. (2026). Radiation-Induced Breast Cancer Attributable to Mammography Screening: Estimation for France in 2019. Journal of Breast Imaging. https://doi.org/10.1093/jbi/wbaf075
Vancouver
Minier N, Sauce J, Sage J, Bonaldi C, Ceugnart L, Cléro E, et al. Radiation-Induced Breast Cancer Attributable to Mammography Screening: Estimation for France in 2019. Journal of Breast Imaging. 2026. doi:10.1093/jbi/wbaf075
BibTeX
@article{Minier2026,
author = {Minier, Nicolas and Sauce, Justine and Sage, Julie and Bonaldi, Christophe and Ceugnart, Luc and Cléro, Enora and Laurier, Dominique and Bernier, Marie-Odile and Rogel, Agnès},
title = {Radiation-Induced Breast Cancer Attributable to Mammography Screening: Estimation for France in 2019},
journal = {Journal of Breast Imaging},
year = {2026},
doi = {10.1093/jbi/wbaf075}
}
EUVIMED